IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v131y2015icp239-246.html
   My bibliography  Save this article

Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India

Author

Listed:
  • Sariola, Salla
  • Ravindran, Deapica
  • Kumar, Anand
  • Jeffery, Roger

Abstract

The World Trade Organisation's Trade Related Intellectual Property Rights [TRIPS] agreement aimed to harmonise intellectual property rights and patent protection globally. In India, the signing of this agreement resulted in a sharp increase in clinical trials since 2005. The Indian government, along with larger Indian pharmaceutical companies, believed that they could change existing commercial research cultures through the promotion of basic research as well as attracting international clinical trials, and thus create an international level, innovation-based drug industry. The effects of the growth of these outsourced and off-shored clinical trials on local commercial knowledge production in India are still unclear. What has been the impact of the increasing scale and commercialisation of clinical research on corporate science in India?

Suggested Citation

  • Sariola, Salla & Ravindran, Deapica & Kumar, Anand & Jeffery, Roger, 2015. "Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India," Social Science & Medicine, Elsevier, vol. 131(C), pages 239-246.
    • Handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:239-246
    DOI: 10.1016/j.socscimed.2014.11.052
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953614007849
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2014.11.052?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Kamat, Vinay R., 2014. "Fast, cheap, and out of control? Speculations and ethical concerns in the conduct of outsourced clinical trials in India," Social Science & Medicine, Elsevier, vol. 104(C), pages 48-55.
    2. Raveendra Chittoor & MB Sarkar & Sougata Ray & Preet S. Aulakh, 2009. "Third-World Copycats to Emerging Multinationals: Institutional Changes and Organizational Transformation in the Indian Pharmaceutical Industry," Organization Science, INFORMS, vol. 20(1), pages 187-205, February.
    3. Anitha Ramanna, 2003. "Interest Groups and Patent Reform in India," Development Economics Working Papers 22346, East Asian Bureau of Economic Research.
    4. Kalpana Chaturvedi & Joanna Chataway, 2006. "Strategic integration of knowledge in Indian pharmaceutical firms: creating competencies for innovation," International Journal of Business Innovation and Research, Inderscience Enterprises Ltd, vol. 1(1/2), pages 27-50.
    5. Bell, Susan E. & Figert, Anne E., 2012. "Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward," Social Science & Medicine, Elsevier, vol. 75(5), pages 775-783.
    6. Anita Ramanna, 2003. "Interest groups and patent reform in India," Indira Gandhi Institute of Development Research, Mumbai Working Papers 2003-006, Indira Gandhi Institute of Development Research, Mumbai, India.
    7. Simpson, Bob & Khatri, Rekha & Ravindran, Deapica & Udalagama, Tharindi, 2015. "Pharmaceuticalisation and ethical review in South Asia: Issues of scope and authority for practitioners and policy makers," Social Science & Medicine, Elsevier, vol. 131(C), pages 247-254.
    8. Dinar Kale & David Wield, 2008. "Exploitative and Explorative Learning as a Response to the TRIPS Agreement in Indian Pharmaceutical Firms," Industry and Innovation, Taylor & Francis Journals, vol. 15(1), pages 93-114.
    9. Sariola, Salla & Simpson, Bob, 2011. "Theorising the 'human subject' in biomedical research: International clinical trials and bioethics discourses in contemporary Sri Lanka," Social Science & Medicine, Elsevier, vol. 73(4), pages 515-521, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Csanádi, Marcell & Ozierański, Piotr & Löblová, Olga & King, Lawrence & Kaló, Zoltán & Botz, Lajos, 2019. "Shedding light on the HTA consultancy market: Insights from Poland," Health Policy, Elsevier, vol. 123(12), pages 1237-1243.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Andrea Coveri & Antonello Zanfei, 2023. "Who wins the race for knowledge-based competitiveness? Comparing European and North American FDI patterns," The Journal of Technology Transfer, Springer, vol. 48(1), pages 292-330, February.
    2. Arindam Mondal & Somnath Lahiri & Sougata Ray, 2021. "Strategic Response to Inward Foreign Direct Investment: A Study of Indian Family Firms," Management International Review, Springer, vol. 61(2), pages 207-233, April.
    3. Irina Jormanainen & Alexei Koveshnikov, 2012. "International Activities of Emerging Market Firms," Management International Review, Springer, vol. 52(5), pages 691-725, October.
    4. Basant, Rakesh & Srinivasan, Shuchi, 2015. "Intellectual Property Protection in India and Implications for Health Innovation: Emerging Perspectives," IIMA Working Papers WP2015-04-01, Indian Institute of Management Ahmedabad, Research and Publication Department.
    5. Jiewei Zu & Jianan Wang & Jun Ma, 2022. "Ambidexterity in a Rapidly Changing Environment of China: Top Management Team Decision Making and Sustained Performance," Sustainability, MDPI, vol. 14(7), pages 1-20, March.
    6. Buckley, Peter J. & Munjal, Surender & Enderwick, Peter & Forsans, Nicolas, 2016. "Cross-border acquisitions by Indian multinationals: Asset exploitation or asset augmentation?," International Business Review, Elsevier, vol. 25(4), pages 986-996.
    7. Larissa Rabbiosi & Stefano Elia & Fabio Bertoni, 2012. "Acquisitions by EMNCs in Developed Markets," Management International Review, Springer, vol. 52(2), pages 193-212, April.
    8. Dew, Kevin & Norris, Pauline & Gabe, Jonathan & Chamberlain, Kerry & Hodgetts, Darrin, 2015. "Moral discourses and pharmaceuticalised governance in households," Social Science & Medicine, Elsevier, vol. 131(C), pages 272-279.
    9. Paola Perez-Aleman, 2011. "Collective Learning in Global Diffusion: Spreading Quality Standards in a Developing Country Cluster," Organization Science, INFORMS, vol. 22(1), pages 173-189, February.
    10. Başaran, Oyman, 2020. "“The self-making of the scientific circumciser (fenni sünnetçi):” the medicalization of male circumcision in Turkey," Social Science & Medicine, Elsevier, vol. 265(C).
    11. Purkayastha, Anish & Kumar, Vikas & Gupta, Vishal K., 2021. "Emerging market internationalizing firms: Learning through internationalization to achieve entrepreneurial orientation," Journal of World Business, Elsevier, vol. 56(5).
    12. Stucchi, Tamara, 2012. "Emerging market firms’ acquisitions in advanced markets: Matching strategy with resource-, institution- and industry-based antecedents," European Management Journal, Elsevier, vol. 30(3), pages 278-289.
    13. Smitha R. Nair & Mehmet Demirbag & Kamel Mellahi, 2015. "Reverse Knowledge Transfer from Overseas Acquisitions: A Survey of Indian MNEs," Management International Review, Springer, vol. 55(2), pages 277-301, April.
    14. Mamo, Laura & Epstein, Steven, 2014. "The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention," Social Science & Medicine, Elsevier, vol. 101(C), pages 155-165.
    15. Purkayastha, Anish & Karna, Amit & Sharma, Sunil & Bhadra, Dhiman, 2021. "Board’s human capital resource and internationalization of emerging market firms: Toward an integrated agency–resource dependence perspective," Journal of Business Research, Elsevier, vol. 135(C), pages 391-407.
    16. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
    17. Sushma Kumari & Vikrant Shirodkar & Steven McGuire, 2023. "Pre-Liberalization Foundations and the FDI-Based Internationalization of SMEs from Emerging Markets," Management International Review, Springer, vol. 63(4), pages 641-671, August.
    18. Gammeltoft, Peter & Filatotchev, Igor & Hobdari, Bersant, 2012. "Emerging multinational companies and strategic fit: A contingency framework and future research agenda," European Management Journal, Elsevier, vol. 30(3), pages 175-188.
    19. Terrence D. Hill & Jason A. Ford & Harvey L. Nicholson, 2022. "Education and polypharmacy: A national study of racial and ethnic variations," Social Science Quarterly, Southwestern Social Science Association, vol. 103(7), pages 1687-1705, December.
    20. Sanjay Jain & Anil Nair & David Ahlstrom, 2015. "Introduction to the Special Issue: Towards a theoretical understanding of innovation and entrepreneurship in India," Asia Pacific Journal of Management, Springer, vol. 32(4), pages 835-841, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:239-246. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.